AWM Investment Company, Inc. - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 61 filers reported holding SPERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
AWM Investment Company, Inc. ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$403,414
-27.4%
333,400
-13.0%
0.06%
-20.0%
Q2 2023$555,930
-70.5%
383,400
-70.5%
0.08%
-70.6%
Q1 2023$1,885,580
-16.2%
1,300,4000.0%0.26%
-21.3%
Q4 2022$2,249,692
-51.1%
1,300,400
-43.5%
0.32%
-53.7%
Q3 2022$4,601,000
+41.9%
2,300,400
+517.1%
0.70%
+67.5%
Q1 2022$3,243,000
-45.7%
372,7550.0%0.42%
-30.2%
Q4 2021$5,968,000
-13.0%
372,7550.0%0.60%
-11.0%
Q3 2021$6,862,000
+31.9%
372,7550.0%0.67%
+30.9%
Q2 2021$5,204,000
-5.2%
372,7550.0%0.51%
-16.2%
Q1 2021$5,487,000
-24.1%
372,7550.0%0.61%
-33.2%
Q4 2020$7,228,000
+29.9%
372,755
-25.3%
0.92%
+0.7%
Q3 2020$5,566,000
+68.8%
498,755
+104.6%
0.91%
+57.8%
Q2 2020$3,298,000
+3.1%
243,755
-38.4%
0.58%
-31.8%
Q1 2020$3,199,000
-29.9%
395,949
-16.5%
0.85%
-4.8%
Q4 2019$4,561,000
-28.1%
474,344
-20.7%
0.89%
-33.8%
Q3 2019$6,342,000
-7.9%
598,3150.0%1.35%
+2.2%
Q2 2019$6,887,000
-4.4%
598,315
+6.4%
1.32%
-7.1%
Q1 2019$7,203,000
+123.5%
562,296
+7.3%
1.42%
+102.3%
Q4 2018$3,223,000
-43.3%
524,025
-3.0%
0.70%
-25.3%
Q3 2018$5,680,000
+175.6%
540,474
+284.8%
0.94%
+173.0%
Q2 2018$2,061,000
-58.7%
140,474
-59.9%
0.34%
-64.2%
Q1 2018$4,987,000
+21.3%
350,0000.0%0.96%
+20.6%
Q4 2017$4,112,000350,0000.80%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders